Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125287671 | 12528767 | 1 | I | 20160628 | 20160705 | 20160705 | EXP | JP-CELGENEUS-JPN-2016066800 | CELGENE | OKUMA Y. TITLE: A PHASE II STUDY OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL PLUS CARBOPLATIN AS THE FIRST-LINE THERAPY IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER.. CANCER CHEMOTHER PHARMACOL.. 2016 JUN 23;. | 0.00 | E | Y | 0.00000 | 20160705 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125287671 | 12528767 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 100 MILLIGRAM/SQ. METER | U | 21660 | 100 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125287671 | 12528767 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | AUC 6 | U | 0 | UNKNOWN | ||||||||
| 125287671 | 12528767 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | AUC 5 | U | 0 | UNKNOWN | ||||||||
| 125287671 | 12528767 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | 6.6 | MG | UNKNOWN | ||||||||
| 125287671 | 12528767 | 5 | C | Palonosetron | PALONOSETRON | 1 | Unknown | 0 | .75 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125287671 | 12528767 | 1 | Non-small cell lung cancer |
| 125287671 | 12528767 | 2 | Non-small cell lung cancer |
| 125287671 | 12528767 | 4 | Product used for unknown indication |
| 125287671 | 12528767 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125287671 | 12528767 | DE |
| 125287671 | 12528767 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125287671 | 12528767 | Acute respiratory failure | |
| 125287671 | 12528767 | Anaemia | |
| 125287671 | 12528767 | Death | |
| 125287671 | 12528767 | Febrile neutropenia | |
| 125287671 | 12528767 | Lung infection | |
| 125287671 | 12528767 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |